BBSRC Portfolio Analyser
Award details
The synthesis and pharmacology of subtype- selective ligands for neuronal nicotinic receptors
Reference
B12081
Principal Investigator / Supervisor
Professor Timothy Gallagher
Co-Investigators /
Co-Supervisors
Ms Sue Wonnacott
Institution
University of Bristol
Department
Chemistry
Funding type
Research
Value (£)
154,669
Status
Completed
Type
Research Grant
Start date
01/01/2000
End date
01/01/2003
Duration
36 months
Abstract
This collaborative study, based on UB-165, a novel, enantiospecific subtype- selective nicotinic agonist, aims to define individual pharmacophores for neuronal nicotinic receptor (nAChR) subtypes, and to use the ligands to characterise native nAChR. A series of structural analogues of UB-165, as well as new classes of ligands, will be generated by efficient chemical synthesis. All ligands will be characterised pharmacologically at defined nAChR subtypes, and used to distinguish presynaptic subtypes in the brain. These results will direct ligand design, generating informative structure-activity relationships and the evolution of new, more critical pharmacophore models that will be significant for rational drug design targeted at these sites. (Joint with award B11785.)
Summary
unavailable
Committee
Closed Committee - Biomolecular Sciences (BMS)
Research Topics
X – not assigned to a current Research Topic
Research Priority
X – Research Priority information not available
Research Initiative
X - not in an Initiative
Funding Scheme
X – not Funded via a specific Funding Scheme
Associated awards:
B11785 The synthesis and pharmacology of subtype- selective ligands for neuronal nicotinic receptors
I accept the
terms and conditions of use
(opens in new window)
export PDF file
back to list
new search